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’ INTRODUCTION
Asthma is a T-helper type 2-driven (Th2) disease character-
ized by airway hyper-responsiveness and eosinophilic in!amma-
tion as well as histological changes of the bronchi including
collagen deposition and mucus overproduction.1 Despite a
growing knowledge of pathophysiological end points in asthma,
comprehensive deciphering of the complex network of interact-
ing mediators is still lacking.
To better understand the implication of new proteic mediators
in intrinsic mechanisms of asthma, it is mandatory to knowwhich
genes, gene transcripts, protein species, and metabolites are
di"erentially expressed during the course of the disease.1b,c As
proteins undergo many post-translational modi#cations that
a"ect their structures and functions, the identi#cation through
appropriate proteomic approaches of their modi#ed phenotypes
and expression levels under pathological conditions may also
convey useful information to discover new potential therapeutic
targets. Proteomic studies of the lung parenchyma imply the
puri#cation and identi#cation of individual proteins from a very
complexmixture consisting of proteins expressed by resident and
in!ammatory cells as well as proteins from extracellular matrix
and plasma. Protein separation by two-dimensional polyacryla-
mide gel electrophoresis (2D-electrophoresis) followed by iden-
ti#cation through mass spectrometry are standard approaches in
proteomics. In this study, we investigate the pathogenesis of
asthma by a 2D-DIGE proteomic approach devoted to discrimi-
nate which proteins frommouse lungs are up- or down-regulated
after acute or long-term allergen exposure.
’MATERIALS AND METHODS
OVA-Induced Asthma Model
Speci#c pathogen-free Balb/c mice (6 weeks-old male) were
used. Two di"erent protocols consisting in acute or chronic
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ABSTRACT: As asthma physiopathology is complex and not fully
understood to date; it is expected that new key mediators are still to
be unveiled in this disease. The main objective of this study was to
discover potential new target proteins with a molecular weight
>20 kDa by using two-dimensional di"erential in-gel electrophor-
esis (2D-DIGE) on lung parenchyma extracts from control or
allergen-exposed mice (ovalbumin). Two di"erent mouse models
leading to the development of acute airway in!ammation (5 days
allergen exposure) and airway remodeling (10 weeks allergen
exposure) were used. This experimental setting allowed the dis-
crimination of 33 protein spots in the acute in!ammation model
and 31 spots in the remodeling model displaying a di"erential
expression. Several proteins were then identi#ed by MALDI-TOF/
TOF MS. Among those di"erentially expressed proteins, PDIA6, GRP78, Annexin A6, hnRPA3, and Enolase display an increased
expression in lung parenchyma frommice exposed to allergen for 5 days. Conversely, Apolipoprotein A1 was shown to be decreased
after allergen exposure in the samemodel. Analysis on lung parenchyma of mice exposed to allergens for 10 weeks showed decreased
calreticulin levels. Changes in the levels of those di"erent mediators were con#rmed by Western blot and immunohistochemical
analysis. Interestingly, alveolar macrophages isolated from lungs in the acute in!ammation model displayed enhanced levels of
GRP78. Moreover, intratracheal instillation of anti-GRP78 siRNA in allergen-exposed animals led to a decrease in eosinophilic
in!ammation and bronchial hyperresponsiveness. This study unveils new mediators of potential importance that are up- and down-
regulated in asthma. Among up-regulated mediators, GRP-78 appears as a potential new therapeutic target worthy of further
investigations.
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exposure to allergen were applied and were approved by the
Animal Ethics Committee of the University of Li"ege.
Mice were sensitized with 2 i.p. injections of 10 !g of
ovalbumine grade V (OVA) (Sigma, St. Louis, MO) adsorbed
to aluminum hydroxide (Pierce Biotechnology Inc., Rockford, IL).
Mice were then exposed to an aerosol of 1% OVA in phosphate-
bu"ered saline (PBS) givenby an ultrasonic nebulizer for 30min/day
during #ve consecutive days for short-term exposure (induction
of acute in!ammation, short-term exposure protocol (STE)) and
during #ve days per even week until day 90 for long-term
exposure (induction of a chronic remodeling, long-term expo-
sure protocol (LTE)). Intratracheal instillations of target si-RNA
(ON-TARGETplus SMARTpool siRNA, Dharmacon CO, IL)
were performed the #rst, third, and last days of allergen exposure.
Each experiment was performed with control mice (n = 10) and
allergen-exposed mice (n = 10). Twenty-four hours after the last
aerosol challenge, mice were anesthetized by intraperitoneal
injection (200 !L) of a mixture of ketamine (10 mg/mL, Merial,
Brussels, Belgium) and xylazine (1 mg/mL, VMD, Arendonk,
Belgium). A tracheotomy was performed by insertion of a 20
gauge polyethylene catheter into the trachea. Mice were venti-
lated with a !exiVent small animal ventilator (SCIREQ, Mon-
treal, Canada) to measure airway hyperresponsiveness to
methacholine aerosol as described elsewhere.1b
Bronchoalveolar Lavage (BAL)
After the sacri#ce of mice, a bronchoalveolar lavage was
performed using PBS/EDTA 0.05 mM (Calbiochem, Darm-
stadt, Germany). After centrifugation of BAL, the supernatant
was frozen at !80 !C for protein assessment and the cell pellet
was resuspended in 1 mL PBS-EDTA 0.05 mM.
Total cells counts were performed by using a Coulter counter Z2
(Beckman, Brea, CA). Di"erential cell counts were performed after
cytocentrifugation and staining with Di"-Quick (Dade, Belgium).
Primary alveolar macrophages were isolated from bronchoal-
veolar lavage !uid (BALF) by a simple adhesion method on
standard plastic culture dishes.
Pulmonary Histology
The left lung was immediately frozen at !80 !C until further
processing and the right lung was infused with 4% paraformal-
dehyde, embedded in para$n and processed for histology.
Sections of 5 !m thickness were cut o" from para$n blocks
and were stained with hematoxylin!eosin. The peribronchial
in!ammation was estimated on hematoxylin-eosin-stained slides
by a score calculated by quanti#cation of peribronchial in!am-
matory cells (eosinophils, lymphocytes, macrophages, etc.), as
previously described by Cataldo et al.2 After Congo Red staining,
the eosinophilic in#ltration in the airway walls was quanti#ed by
manual count in randomly selected bronchi and normalized to
the perimeter of corresponding epithelial basement membrane
de#ning an eosinophilic in!ammatory score.
To assess airway mucus production, lung sections were
analyzed using the Alcian Blue method. For each sample, positive
cells percentage was evaluated. The peribronchial collagen
deposition was estimated using Masson’s Trichrome staining.
Quanti#cation was performed as previously described by Di
Valentin et al.3 Blood was drawn from the heart at the time of
sacri#ce for serum OVA speci#c IgE measurement.4
2D-Difference Gel Electrophoresis (2D-DIGE)
Lung Sample preparation and 2D-DIGE. All electropho-
resis reagents and instrumentation were obtained from GE
Healthcare. Total proteins were extracted from lungs by an
overnight incubation of crushed tissue with lysis buffer contain-
ing 7 M Urea, 2 M Thiourea, 2% CHAPS and 50 mM Tris
(pH 9), followed by centrifugation at 13 200 rpm (20 min).
After precipitation with the 2D Clean-Up Kit, protein concen-
trations were measured using the PlusONE 2-D Quant Kit. To
label proteins, 25 !g of each protein samples were incubated
with 200 pmol of CyDye (Cy3, Cy5). A pool containing equal
amounts of all samples was also prepared and labeled with Cy2
to be used as an internal standard. The labeling was stopped by
adding 10 mM lysine. Experiments were performed in triplicate
(3 independent sham- and 3 independent allergen-exposure
samples in each model).
First-dimension isoelectric focusing was performed on 24-cm
IPG strips, with a 3!10 linear pH gradient, in an IPGphor II
instrument. The strips were rehydrated overnight with a mixture
of two labeled samples (Cy3 and Cy5) plus the internal standard
in 450 !L of a solution containing 7 M urea, 2 M thiourea, 2%
ASB-14, 0.2% dithiothreitol and 0.5% IPG bu"er 3!10 NL .
Focusing was conducted for 1 h at 200 V, 1 h at 500 V, 1 h at 1000
V, 6 h at 8000 V. The strips were then incubated with equilibra-
tion bu"er (6 M urea, 50 mM Tris pH 8.8, 30% glycerol, 1.6%
sodium dodecyl sulfate and a trace of bromophenol blue)
containing 1% dithiothreitol and then 5% iodoacetamide, each
time for 15 min. They were then deposited on top of a 12.5%
SDS-PAGE gel. The second-dimension separation was per-
formed overnight in an Ettan Dalt II system.
Gel Analysis
Once the second dimension step was carried out, each gel
(3 gels in eachmodel) was scanned at three di"erent wavelengths
corresponding to the di"erent CyDyes with a Typhoon 9400
Laser Scanner (GEHealthcare). Then all images were analyzed
using DeCyder 2D Software 6.5 (GE Healthcare). A cuto"
value was set at a 1.2-fold increase or decrease in normalized
spot volume, and statistical di"erences in spot intensities were
analyzed by Student t test with p < 0.05 (with visual inspection
of the results).
Protein Identification
The spots of interest were excised from the gel with the Ettan
Spot Picker robot (GEHealthcare) and were collected in 96-well
plates designed for the digestion of proteins. Spots were washed
and desalted in 50 mM ammonium bicarbonate/methanol
(50% v/v), followed by acetonitrile (75% v/v, ACN). Then they
were digested with Trypsin Gold (MS grade, Promega, Madison,
WI, 10 mgmL!1 in 20 mM ammonium bicarbonate) using the
Ettan Digester robot (GE Healthcare) from the Ettan Spot
Handling workstation. Automated spotting of the samples was
carried out with the spotter of the same Workstation (GE
Healthcare). Peptides dissolved in a 50% ACN containing
0.5% TFA (0.7 mL) were spotted on MALDI-TOF disposable
target plates (4800, Applied Biosystems, Foster City, CA) prior
to the deposit of 0.7 mL of CHCA (7 mg/mL, 50% v/v ACN,
0.1% v/v TFA, Sigma Aldrich, St. Louis, MO). Peptide mass
determinations were carried out using the Applied Biosystems
4800 Proteomics Analyzer (Applied Biosystems). Both PMF and
MS/MS in re!ectron mode analyses were carried out with the
samples. Calibration was carried out with the peptide mass
calibration kit for 4700 (Applied Biosystems). Proteins were
identi#ed by searching in Swiss-Prot, TREMBL and NCBI data-
bases using MASCOT (Matrix Science, www.matrixscience.com,
London, U.K.). All searches were carried out using a mass window
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of 100 ppm and with “Mus musculus” as taxonomy in NCBInr
database (http://www.ncbi.nlm.nih.gov/) and 0.5 Da of tol-
erance on MS/MS fragments. The search parameters allowed
#xed modi#cations for cysteine (carboxyamidomethylation)
and methionine (oxidation) and variable modi#cations on
tryptophan (double oxidation or kynurenin). Two missed
cleavages were allowed, and the peptide charge was set at
+1. All of the identi#cations were manually veri#ed and
validated.
Protein Validation Approaches
Western Blot. Lung sample proteins were separated under
reducing conditions using NuPage 12% Bis-Tris Gels (Invitro-
gen, Carlsbad, CA), transferred, and incubated with primary
antibodies: rabbit anti-hnRNP A3 (Santa Cruz Biotechnology,
Foster City, CA), chicken anti-PDIA6 (Abcam, U.K.), rabbit
anti-Calreticulin (Santa Cruz Biotechnology), rabbit anti-
Annexin VI (Abcam), rabbit anti-Apolipoprotein A1 (Abcam),
rabbit anti-GRP78 BiP (Abcam).
Figure 1. Characterization of airway responsiveness, in!ammation and remodeling. (a) Measurement of airway responsiveness: Airway resistances
(Enhanced pause - R) were measured after increasing concentrations of methacholine (0!100 mg/mL !0!12 mg/mL). Measurements were
performed by barometric plethysmography (left panel) or by the forced oscillation technique (FlexiVent, right panel) 24 h after the last allergen or PBS
exposure. (b) Di"erential BAL !uid cell counts were performed after cytocentrifugation in both acute in!ammation, short-term exposure (STE), and
chronic remodeling protocols, long-term exposure (LTE). (c) In!ammation score measured onH&E stained 5 !m sections (seeMaterials andMethods
for description of in!ammation score). (d) Characterization of allergen-induced remodeling: Morphometric quanti#cation of smooth muscle alpha-
actin in the airway walls of mice after short- (acute in!ammation protocol) or long-term (chronic remodeling protocol) exposure to allergens. (e) Tissue
eosinophil in#ltration was assessed in the peribronchial area by congo red staining and cell numbers were counted by microscope examination. (f and g)
Morphometric quanti#cation of goblet cells and subepithelial collagen deposition in the airways of mice after chronic exposure to allergen after PAS and
Masson’s trichrome staining, respectively.
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Incubation with corresponding secondary antibody conjugated
to horseradish peroxidase was followed and signal was detected
using the enhanced chemiluminescence (ECL) kit (Perkin-Elmer,
Waltham, MA) as recommended by the manufacturer.
Western blots were analyzed by densitometry scanning. The
intensity of each band was measured with the Quantity One
software (Biorad, Hercules, CA). Proteins levels were normal-
ized using GAPDH signal used as an internal standard.
Immunohistochemistry
Endogenous peroxidase activitywas blocked by incubating tissue
sections in 3% hydrogen peroxide (H2O2). After depara$nization,
Figure 2. Representative 2D-DIGE: Distribution of di"erentially expressed protein spots mice in lung extract after short-term exposure (a) and in long-
term exposure (b) to allergens or placebo (PBS). Each spot name relates to data shown in Table 1. Samples from one control and one allergen-exposed
mice and internal standard were loaded in each gel (3 di"erent gels in each model). Internal standard was a pool of all samples from acute and
chronic model.
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slides were permeabilized in 1% triton X-100/PBS and nonspeci#c
binding was blocked in normal goat serum (Annexin A6, Enolase
and Calreticulin) or in 10% BSA (PDIA6, GRP78, hnRNPA3 and
RSMA). Tissues sections were then incubated with rabbit anti-
Annexin VI (Abcam), rabbit anti-Enolase (Abcam), rabbit anti-
Calreticulin (Santa Cruz Biotechnology), rabbit anti-PDIA6
(Abcam), rabbit anti-GRP78 (Abcam), rabbit anti-hnRNPA3
(Santa Cruz Biotechnology) or mouse anti-R smooth muscle actin
(Dako). Secondary antibodies were coupled either to FITC-POD
(RSMA) or to biotin (Annexin A6, Enolase, Calreticulin, RSMA,
PDIA6, GRP78 and hnRNPA3). Peroxidase activity was revealed
using 3-amino, 9-ethyl-carbazole (AEC) staining (RSMA) or
Table 1.
Figure 3. Validation of identi#ed protein candidates. Western blot analyses for (a) Apolipoprotein A1, (b) PDIA6, (c) GRP78, (d) Annexin A6, (e)
hNRPA3, (f) Enolase of representative lung extracts from acute in!ammatory protocol and (g) calreticulin from chronic remodeling protocol. Only 3
representative examples of each group in both models are showed in this #gure, but statistical analyses were performed on all studied samples.
(*Mann!Whitney U test, p-value <0.05).
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3!30diaminobenzidine hydrochlorid kit (DAB) after incubation
with streptavidin/HRP complex (Dako).
Cell Isolation and Flow Cytometry
Lungs were digested one hour at 37 !C in 1 mg/mL collagenase
A (Roche, Vilvoorde, Belgium) in HBSS. Interstitial macrophages
(IMs) and alveolar macrophages (AMs) were sorted by !ow
cytometry (FACSAria, Becton Dickinson) based on their di"eren-
tial F4!80/CD11c expression (eBioscience, San Diego, CA and
BDBiosciences, Franklin Lakes,NJ, respectively). Staining reactions
were performed at 4 !C. Cells were incubated with 2.4G2 Fc
receptor (CD16/CD32) antibodies to reduce nonspeci#c binding.
Statistical Analysis
Comparison (Western blot and immunohistochemistry) be-
tween groups (n = 10/group) were performed using Mann!
Whitney test. Results are reported as mean ( SEM. P-values
<0.05 were considered as statistically signi#cant.
’RESULTS
Characterization of Allergen-Induced Airway Responsive-
ness, Inflammation and Remodeling
To assess the validity of asthma models used in 2D-DIGE
study, the airway responsiveness was measured 24 h after the
last allergen challenge by direct measurement of lung resis-
tances by using the Flexivent ventilator and whole body plethy-
smography (enhanced pause (Penh) measurement) and found
to be increased after allergen exposure in short-term exposure
model (Figure 1a). As expected from previous studies,5
no di"erence was seen in the long term exposure model (data
not shown).
Eosinophil numbers were signi#cantly increased in BAL and in
bronchial walls after allergen exposure (Figure 1b!e). Allergen-
exposed mice displayed signi#cantly more in!ammatory cells in
the peribronchial area on lung sections stained by H&E
(Figure 1c). Representative picture of this results is presented
in the Supporting Information (Figure 1SA). Features of airway
remodeling were studied on histologic lung sections by using
speci#c stainings. Alpha-smooth muscle actin staining showed
that mice exposed to allergens for short and long durations (STE
and LTE protocols) displayed thickened layers of smoothmuscle
cells in the airway walls (Figure 1d). Numbers of PAS-positive
mucous-secreting Goblet cells were higher after chronic allergen
exposure (Figure 1f). Collagen deposition assessed by Masson’s
trichrome staining was increased only after long-term exposure
(LTE) to allergens (Figure 1g). Representative picture of this
result is presented in the Supporting Information (Figure 1SB).
Finally, anti-OVA speci#c IgE levels were found to be signi#-
cantly elevated in allergen immunized and challenged mice as
compared to allergen immunized and sham (PBS) exposed
animals (data not shown).
Proteomic Profile after 2D-DIGE Analysis
2D-DIGE was used to identify proteins that are di"erentially
expressed in allergen-exposed mice in acute in!ammation and
chronic remodeling models. Spots general distribution patterns
were similar in both groups of each model (Figure 2a!b).
Nevertheless, 64 di"erent spots showed a greater than 1.2-fold
change in normalized volume with a t-test score below 0.05 in
the Biological Variation Analysis in allergen-exposed versus
sham-exposed animals, therefore suggesting di"erential protein
expression. In the short term exposure protocol, the intensity of
19 spots increased while the intensity of 14 spots decreased
upon allergen exposure. In contrast, when mice were exposed
for longer periods to allergens, only 9 spots were increased
while 22 spots were decreased after allergen exposure. The list
of proteins identi#ed by MALDI-TOF/TOF after spot picking
is shown in Table 1 and most are illustrated in Figure 2. Nine of
the spots failed to yield any identi#cation, giving an overall
identi#cation success rate of 70% for this study.
Validation of 2D-DIGE Results by Western Blot Analysis
To con#rm the 2D-DIGE results and protein identi#cations
by MALDI-TOF/TOF, we performed Western blots using
antibodies against 7 di"erent proteins selected in Table 1, based
on antibody availability. We therefore con#rmed that PDIA6,
GRP78, Annexin A6, hnRNPA3, and Enolase production was
increased in lung parenchyma after short-term allergen exposure
while Apolipoprotein A1 was less abundant in the same condi-
tions only in the short-term exposure model (Figure 3). Similar
results were obtained after long-term exposure (data not shown).
Calreticulin levels were less important in lung parenchyma after
long allergen exposure protocols as described in Figure 3, again
increased level of this protein were demonstrated in the short-
term exposure model (data not shown).
Figure 4. Validation of identi#ed protein candidates by immunohisto-
chemistry. (A!J) Immunohistochemical analysis of sham or allergen-
exposed mice lung sections using antibodies directed against (A!B)
PDIA6, (C!D) GRP78, (E!F) Annexin A6, (G!H) hNRPA3, and
(I!J) Enolase from short-term exposed mice (STE). (K!L) Immunohis-
tochemical analysis of sham or allergen-exposed mice lung sections using
antibody directed against Calreticulin from long-term exposedmice (LTE).
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Validation of 2D-DIGE Results by Immunohistochemistry
After short time exposure to allergens (STE), PDIA6 immunos-
taining was more frequently detectable in in!amed lungs as com-
pared to controls (Figure 4a!b). In particular, an intense staining
was observed in alveolar macrophages and some bronchial epithelial
cells. GRP78, Annexin A6, hnRNPA3, and Enolase proteins
(Figure 4c!h) were also detectable by immunohistochemistry with
far higher intensities in the allergen-exposed mice. For those
proteins, staining was mainly located in lung parenchyma macro-
phages and in bronchial epithelial cells of allergen-exposed mice.
Study of GRP78 Expression in Alveolar and Interstitial
Macrophages
An immunocytochemical analysis of GRP78 production was
performed on cells (macrophages) cultured from bronchoalveolar
lavage and on macrophages from lung parenchyma sorted by !ow
cytometry and cytocentrifuged. In BAL cells, anti-GRP78 stained a
majority of cells from allergen-exposed as compared to sham-
exposed mice (Figure 5a). Sorted alveolar macrophages (AM) and
interstitial macrophages (IM) were cytocentrifuged in order to
perform an immunocytological staining that labeled mostly AM as
compared to IM population from allergen-exposed mice. GRP78
protein levels measured byWestern blot were also largely increased
in AM from allergen-exposed as compared to sham-exposed mice
or to IM in both conditions (Figure 5b).
Validation of GRP78 as a Potential Therapeutic Target in
Asthma
To demonstrate a possible pathological role related to higher
GRP78 levels observed in lungs of mice after allergen exposure,
we tested the e"ects of reducing the expression of GRP78 in vivo
using anti-GRP78 siRNA treatment. GRP78 levels measured by
Western blot in protein extracts from lung parenchyma were
decreased in a dose-dependent manner following intratracheal
instillation of siRNA (Figure 5c). GRP78 inhibition by intra-
tracheal instillation of siRNA led to a signi#cant dose-dependent
decrease of eosinophil percentages in BAL and bronchial hyper-
responsiveness from allergen-exposed mice (Figure 5d!e).
’DISCUSSION
There is a considerable interest in proteomic studies per-
formed on samples from patients or animals su"ering from
chronic in!ammatory diseases such as asthma. These techniques
allowing a large-scale study of proteins unveil new pathophysio-
logical mechanisms and identify new biomarkers and/or poten-
tial therapeutic targets. We previously reported a proteomic
study in a preclinical asthma model using SELDI-TOF-MS for
the detection of low molecular weight (mostly <20 kDa)
proteins.6 The present study has been designed to address the
modulation of highmolecular weight proteins in the same animal
models of asthma and has been performed by using 2D-DIGE
since this technique is recognized as being able to resolve
complex biological samples.7
In the present study, mice were characterized regarding main
features of asthma and displayed a full asthmatic phenotype
including bronchial hyperresponsiveness, eosinophilic in!amma-
tion, and bronchial remodeling. 2D-DIGE analysis performed on
whole lung extracts of individual animals revealed, among other
di"erentially expressed proteins, increased amounts of PDIA6,
Figure 5. Modulation of GRP78 production in macrophages and GRP78 inhibition experiments. (a) Immunohistochemistry performed with an anti-
GRP78 antibody on cultured bronchoalveolar lavage (BAL) macrophages and interstitial or alveolar macrophages isolated from whole lung extracts of
sham or allergen-exposed mice (acute in!ammation protocol (STE)). (b)Western blot with anti-GRP78 antibody performed on interstitial and alveolar
macrophages isolated from lungs of sham or allergen-exposed mice (acute in!ammation protocol (STE)). These macrophages were sorted by !ow
cytometry (see Materials and Methods section). (c) Levels of GRP78, measured by Western blot, were decreased after instillations of siRNA (50, 100,
and 500 mM). (d) GRP78 inhibition experiments: Anti GRP78 siRNA (50, 100, and 500 mM) was administered intratrachelly in mice and eosinophil
percentages in BAL !uid were measured. (e) Measurement of airway resistance.
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GRP78, Annexin A6, hnRPA3, and Enolase in lung parenchyma
from mice exposed to allergens for 5 days. On the contrary,
Apolipoprotein A1 was found to decrease in the samemodel after
allergen exposure. Moreover, Calreticulin was shown to decrease
in lung parenchyma of mice exposed to allergens for 10 weeks.
To the best of our knowledge, this study reports for the #rst time
a 2D-DIGE study of proteins di"erentially expressed in long-
term allergen-exposed animals allowing the study of key events
occurring when airway remodeling establishes.
The rationale to perform the present study on two mice
models of asthma is that these models allow a full characteriza-
tion of the asthmatic phenotype since they have been previously
shown to involve a reproducible in!ammation and enable the
study of lung parenchyma after animal sacri#ce.4 In particular, we
used the Th2-prone BALB/c mice known to constitute a reliable
model to study asthma phenotype.4,5,8 We validated our #ndings
regarding protein di"erential expression in our 2D-DIGE anal-
ysis by Western blotting and immunohistochemical analysis in
order to generate additional information about the cells respon-
sible for an overexpression of various lung proteins in the context
of allergen-induced in!ammation. Although previous authors
have studied asthma models by using the 2D-DIGE technique,
the present study is the #rst to compare both short-term and
long-term allergen exposures regarding protein di"erential
expression.9 Some of the previous authors have also studied
nonallergic asthma, including some models of occupational
asthma induced by various agents including toluene di-
isocyanate.10 Although almost all previous 2D-DIGE studies
have been performed either on BALF or subcompartments of
lung tissue (e.g., lymph nodes or bronchial epithelium), we
decided to conduct the present on whole lung homogenized to
unveil potential new informations on the processes leading to
airway in!ammation and remodeling without focusing on the
immunological mechanisms.9a,b,10a,11 Some authors have also
used 2D-DIGE studies in such models to study the e"ects of
steroids on allergen-induced in!ammation.12 Very recently,
Verrils et al. reported that 2D-DIGE applied to human serum
might help to diagnose asthma and COPD by de#ning a set of
upregulated proteins.13
Some of the proteins like Enolase, Apolipoprotein A1, Calre-
ticulin, and GRP78 identi#ed in our study are in the “TOP 15
most often identi#ed di"erentially expressed proteins” estab-
lished by Petrak et al.14 This reinforces the probability that those
mediators could be considers key players in various biological
pathways.
Among validated proteins, GRP78, PDIA6, and calreticulin
are considered chaperone proteins. These proteins are mainly
found to be associated in the EIF2 complex and are often
implicated in cellular response to stress. Therefore, it is
potentially interesting to study these proteins since increased
cellular stress occurs during the development of allergic
in!ammation in the airway and could account per se for the
increased levels of these proteins detected after acute in!am-
mation protocol.
We report that the production of GRP78 is higher in the lung
parenchyma in the context of acute allergen-induced in!amma-
tion and is detectable in alveolar macrophages in immunohis-
tochemistry. To document the implication of GRP78 in
pathophysiological mechanisms of asthma, we performed a
RNA interference study by instillation of anti-GRP78 siRNA,
allowing a signi#cant decrease of GRP78 protein expression in
the lungs. Once GRP78 production was inhibited, bronchial
responsiveness and airway in!ammation decreased, suggesting
that inhibition of GRP78, a target unveiled by this proteomic
study, might become a potential new therapeutic tool in asthma.
This is the #rst time that a single study reports mediator found to
be overexpressed in asthma models that e"ectively play a
determinant role in the pathophysiology of allergen-induced
airway in!ammation. GRP78 expression has been previously
reported to increase in chronic diseases such as atherosclerosis,15
neurologic disorders (Alzheimer’s and Parkinson’s disease),16
and cancer.17 This protein belongs to the chaperone protein
family but probably playsmultiple roles in vivo since it is detected
both in the endoplasmic reticulum and at the plasma membrane
where it interacts with various extracellular signals such as R2-
macroglobulin, Plasminogen Kringle 5, T-Cadherin, etc.18 To
date, the precise mechanisms implicating GRP78 in the cascade
leading to the asthma phenotype is not fully deciphered, but one
can hypothesize that stress-induced damages following allergen
exposure (activated cells releasing proteases or oxidants) might
be responsible for a GRP78-dependent activation of various
intracellular pathways. Indeed, activation of Phosphatidylinositol
3-kinases/Akt and Ras/MAPkinase by a GRP78 dependent
mechanism has been reported in cancer and in!ammation,
therefore leading to the activation of NFkB and mdm2 among
other pathways.18c,19 Taking into account the properties of
these intracellular pathways and their implication in cell survival
and proliferation, one can expect that they could also play a role
in airway remodeling reported in asthma including smooth
muscle cells proliferation and modi#ed epithelium and conjunc-
tive tissue cells such as #broblasts.20 As GRP78 has been
recognized as an angiogenesis promoting agent, a role for this
protein in chronic asthma-related angiogenesis could also be
hypothesized.21 In!ammatory cell survival could also be a"ected
by GRP78 stimulation.22 Interestingly, it was recently reported
that epigallocatechins gallate, displaying biological activities as
GRP78 inhibitor, is e"ective in controlling allergen-induced
asthma in a Guinea Pigs model of asthma con#rming that our
#nding of a key role for GRP78 in asthma physiopathology
should be studied more intensively.23 Further studies using
GRP78 deletion mouse transgenes could be informative, but
they would require a targeted deletion in adult lung tissue since
the GRP78-de#cient mice die early after birth.24
PDIA6 is another protein up-regulated in our model of acute
asthma. This protein also acts as a folding chaperone and is
mainly located in the endoplasmic reticulum but also on the cell
surface.25 Interestingly, it has been previously reported that
PDIA6 gene silencing interferes with the shedding of the major
histocompatibility complex class-I-related ligand (MICA), which
in turn has been linked to asthma when genetic polymorphisms
are sought in large human populations.26
Annexin A6 plays a role in calcium handling in muscle
cells.27 This protein could therefore potentially interact with
muscle function and might take part to smooth muscle
hyperresponsiveness found in asthma.27 The phospholipid-
binding protein Annexin A6 is a potential S100A8/A9 binding
protein.28 Halayko et al. hypothesized that S100A8/A9 could
be a mediator in asthma in!ammation and remodeling since
S100A8/A9 induce cell proliferation, in!ammation, collagen
synthesis, and cell migration.29
HNRPA3 was reported as overexpressed in acute asthma in
our model. This protein is probably active in controlling RNA
tra$cking from nucleus to cytoplasm. This is the #rst report
describing a modulation for this protein in asthma.30
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Alpha-enolase was found to be overexpressed in the acute
asthma model. This protein is an autoantigen that can give rise to
signi#cant titers of antialpha-enolase autoantibody. Interestingly,
these antialpha-enolase antibodies have been recognized as being
a hallmark of severe asthma.31 Our work is the #rst report
suggesting an up-regulation of this protein in acute asthma,
and one could speculate that such an overexpression might be
triggering autoantibodies production in asthma. However, this
hypothesis has to be con#rmed, and the precise role of alpha-
enolase is still to be unveiled.
Apolipoprotein A1 is down-regulated in our chronic asthma
model. This #nding is in line with a very recent report showing
that this protein is also down-regulated in chronic human
COPD.32 There are indeed many indications in the current
literature for a protective role of apolipoprotein A1 against
in!ammatory diseases such as LPS-induced in!ammation.33
Moreover, a recent report shows that use of apolipoprotein A1
to remove the pro-in!ammatory lipids in a mouse model of
asthma provokes an amelioration of asthma phenotype, there-
fore con#rming that studying this protein might be interesting
in asthma.34
Another chaperone protein, calreticulin is down-regulated in
mice chronically exposed to allergen. Calreticulin is mainly
located inside the endoplasmic reticulum and interacts with
calcium.35 This #nding is not in line with a previous report from
Kypreou et al. showing that calreticulin was up-regulated in a
model of bleomycin-induced lung #brosis36 and after cigarette-
smoke exposure.37 Since membrane-bound calreticulin is a
mediator favoring e"erocytosis,38 one can hypothesize that
decreased levels of this protein found in the lungs from aller-
gen-exposed mice might contribute to a perpetuation of the
in!ammation rendering the phagocytosis of apoptotic cells less
e$cient. Further studies including a study of the clearance of
apoptotic cells are needed to validate this hypothesis.
In conclusion, we report that a 2D-DIGE proteomic study
allows the discovery of many potential mediators of asthma
with a molecular weight >20 kDa. Among those, we report the
increased expression of GRP78 whose inhibition leads to a
signi#cant decrease of bronchial hyper-responsiveness and
in!ammation. This #nding validates the use of proteomics to
unveil potential new targets in in!ammatory diseases and
strongly suggests a role for this protein in asthma physiopathol-
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